The role of anti-IgE therapies in the treatment of asthma
The role of anti-IgE therapies in the treatment of asthma
The prevalence of asthma, a chronic inflammatory disease often linked to allergy, is on the increase. The introduction of a blocking anti-IgE monoclonal antibody (omalizumab) as a new therapy has not only confirmed the pathogenic role of IgE in asthma but has also provided a novel therapy for a chronic severe disease where there are limited therapeutic options.
483-486
Babu, K.S.
b21f201e-3285-4943-9347-a1a3c8727a00
Holgate, S.T.
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
2002
Babu, K.S.
b21f201e-3285-4943-9347-a1a3c8727a00
Holgate, S.T.
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
Babu, K.S. and Holgate, S.T.
(2002)
The role of anti-IgE therapies in the treatment of asthma.
Hospital Medicine, 63 (8), .
Abstract
The prevalence of asthma, a chronic inflammatory disease often linked to allergy, is on the increase. The introduction of a blocking anti-IgE monoclonal antibody (omalizumab) as a new therapy has not only confirmed the pathogenic role of IgE in asthma but has also provided a novel therapy for a chronic severe disease where there are limited therapeutic options.
This record has no associated files available for download.
More information
Published date: 2002
Identifiers
Local EPrints ID: 26918
URI: http://eprints.soton.ac.uk/id/eprint/26918
ISSN: 1462-3935
PURE UUID: 8ab7b83d-e7f3-4ccb-bd46-b382fb256d3d
Catalogue record
Date deposited: 25 Apr 2006
Last modified: 08 Jan 2022 03:51
Export record
Contributors
Author:
K.S. Babu
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics